New Century Health
New Century Health is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at New Century Health.
New Century Health is a company.
Key people at New Century Health.
New Century Health is the nation's leading specialty care management company, focusing on oncology and cardiology patients.[1][2][3] It partners with specialty providers and health plans to deliver clinical decision support and population health management tools, ensuring high-quality, affordable care through value-based programs that integrate advanced technology with clinical expertise to improve outcomes and reduce costs.[1][2][5] As a wholly owned subsidiary of Evolent Health since 2018, it employs 201-500 people, generates $73.4 million in revenue, and holds URAC accreditation since 2011 plus NCQA Utilization Management accreditation since 2020.[1]
The company serves health plans, providers, and patients in cancer and cardiology, addressing challenges like high costs and care variability by providing evidence-based pathways, prior authorization tools, and data analytics for better decision-making.[1][4]
New Century Health emerged as a pioneer in specialty care management, with a company overview video dating back at least 12 years (circa 2013), indicating operations by the early 2010s.[6] It built its reputation as the national leader in value-based programs for oncology and cardiology before its acquisition.[2][3]
In September 2018, Evolent Health acquired New Century Health to expand its specialty care capabilities, integrating it as a wholly owned subsidiary.[3] This pivotal moment accelerated its scale, leveraging Evolent's resources while maintaining focus on innovative solutions for cancer and cardiology management.[1][4] Key milestones include URAC accreditation in 2011 and NCQA accreditation in 2020, underscoring its evolution toward recognized excellence in utilization management.[1]
New Century Health rides the wave of value-based care transformation in healthcare, where shifting from fee-for-service to outcomes-driven models demands data-powered specialty management amid rising oncology and cardiology costs.[1][2] Its timing aligns with post-2018 consolidation via Evolent, capitalizing on digital health adoption for prior auth automation and pathway adherence.[3][5]
Market forces like escalating specialty drug prices and payer-provider pressures favor its tools, influencing the ecosystem by standardizing care quality and enabling scalable population health strategies.[1][4] As a subsidiary, it amplifies Evolent's footprint, contributing to broader tech-enabled efficiencies in U.S. healthcare delivery.
New Century Health is poised to expand its oncology and cardiology dominance through Evolent's platform, potentially integrating AI-driven predictive analytics for even earlier interventions.[1][3][5] Trends like personalized medicine and regulatory pushes for transparency will shape its growth, enhancing its role in cost containment.
Its influence may evolve toward whole-population specialty management, solidifying leadership in affordable, high-quality care as healthcare digitizes further—echoing its founding promise of transforming patient outcomes nationwide.[2]
Key people at New Century Health.
